Vinzent Rolny

Title: Vinzent Rolny: Innovator in Heart Failure Diagnosis

Introduction

Vinzent Rolny is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of heart failure. His innovative approach has the potential to improve patient outcomes through more accurate diagnoses.

Latest Patents

Vinzent Rolny holds a patent related to the differentiation between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF). The patent, titled "IGFBP7 ratio for HFpEF," outlines a method that involves determining the amounts of IGFBP7 (Insulin-like growth factor-binding protein 7), a BNP-type peptide, and optionally CRP (C-reactive protein) in a sample from a subject. The method calculates a ratio of these components to differentiate between the two types of heart failure, thereby aiding in diagnosis.

Career Highlights

Throughout his career, Vinzent Rolny has worked with prominent companies in the healthcare sector. He has been associated with Roche Diagnostics Operations, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in medical diagnostics and innovation.

Collaborations

Vinzent has collaborated with notable professionals in his field, including Kai Habben and Anika Mang. These collaborations have likely enriched his work and contributed to the development of his patent.

Conclusion

Vinzent Rolny's contributions to heart failure diagnostics exemplify the impact of innovation in healthcare. His patent for differentiating between HFpEF and HFrEF represents a significant advancement in medical technology.